ENAFF yields 116.96% · PFE yields 6.13%● Live data
📍 ENAFF pulled ahead of the other in Year 1
Combined, ENAFF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ENAFF + PFE for your $10,000?
Enablence Technologies Inc., together with its subsidiaries, designs, manufactures, and sells optical components and subsystems for local access topologies, metro, and long-haul markets in Canada and the United States. The company provides silica-based PLC optical chips used in both multiplexer and demultiplexer assembly applications and can support 400G and higher bandwidth speeds; and optical chips to serve CWDM-NRZ and FR4-PAM4 applications. It also offers coarse wavelength division multiplexing, a preferred protocol for datacenter networks; LAN-wavelength division multiplexing for 5G networks and datacenters; and dense wavelength division multiplexing, an original driver of optical telecommunications. The company serves telecommunications, cloud data centers, sensor systems, and aerospace and research applications. Enablence Technologies Inc. was incorporated in 2006 and is headquartered in Ottawa, Canada.
Full ENAFF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.